Pricing pressures are forcing Governments / healthcare authorities to prioritize better health outcomes at reduced costs. While true innovation will continue to be relevant, the government is increasingly promoting the prescription of generics and biosimilars.
It is critical for all companies to invest strategically and differentially in the capabilities that create future value for all stakeholders. Life sciences companies in India, must determine how they can seize the upside of disruption in today’s transformative age to maintain leadership in the evolving generics industry and simultaneously start gaining market share in the biosimilars and personalized medicines market.
BioAsia 2019 is themed on ‘Life Sciences 4.0: Disrupt the disruption’ where the global industry experts will share their thoughts on global trends and ramifications for all industry stakeholders viz. companies, policy makers, healthtech companies, startups, hospitals, scientists, etc. The event is scheduled from 25-27 February 2019 at HICC, Hyderabad. You can check more details regarding the event at http://2019.bioasia.in/
Event Name: BioAsia 2019 - Life Sciences 4.0
Event Venue: Hyderabad International Convention Center [HICC], Hyderabad
Event Date: 25th to 27th Feb, 2019
Contact number (with country & area code): +91 91000 61598
Email ID: firstname.lastname@example.org
Event URL: http://2019.bioasia.in/
Event Organizer: Federation of Asian Biotech Associations & Govt. of Telangana